The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies. Provided herein are egg protein formulations for use in the treatment of egg allergy. Also provided herein is a method for identifying and manufacturing egg protein formulations.
